
Medical Design Briefs - June 2023
		     
   
        Fighting Cancer with Real-Time Diagnostics
A Real-Time diagnostics solution has recently been cleared by the FDA. The results would allow clinicians intraprocedural identification and interpretation to properly assess tissue samples for adequacy. Developed by Aquyre Biosciences after a decade of research, CelTivity™ provides real-time cancer diagnostics in the operating room and private practice labs.

          Dynamic cell imaging of immune cells inflamed breast tissue  enhances cellular contrast by capturing residual microscopic intracellular  movements in freshly excised tissue.  
        
   Inadequate  real-time tissue assessment of biopsies from different cell types, like cancer  cells, immune cells, granuloma, and others, forces proceduralists, such as  bronchoscopists and radiologists, to choose between intraprocedural partial  tissue adequacy assessment, rapid on-site evaluation (ROSE), or sending tissue  samples for full pathology review. Neither truly answers the question, “Do we  have enough cells to submit to pathology for the best chance of a conclusive  diagnosis?” This can lead to prolonged delay for patient results, the need for  a redo procedure, and potential delays for treatment options for the patient.
  
  Consider  lung biopsies, which are excised from patients and then sent to the laboratory  for advanced cancer testing. These tests require that patients have an adequate  amount of high-quality tissue to conduct advanced tests such as EGFR, kRas, or  PD-1/PDL-1. To collect these biopsies, transthoracic needle biopsy (TTNA) is  commonly used, which requires a needle to be inserted through the chest wall  from outside the body. The risk of a collapsed lung (pneumothorax) can result  in an average of 20 percent of procedures. Navigational bronchoscopy has  emerged as a technology to collect lung biopsies with a lower risk of complications.
  
  A  better solution would be to assess tissue adequacy intra-procedurally, to interrogate  and image the biopsy in its entirety, to determine: Do we have the tissue? What  exactly are we looking at (cancer cells, immune cells, granuloma)? And, do we  have enough cells to submit to pathology to gain the best chance of a  conclusive diagnosis? The results would allow clinicians intraprocedural identification  and interpretation to properly assess tissue samples for adequacy.
 Real-Time  Diagnostics
Real-Time  Diagnostics
Such  a solution has recently been cleared by the FDA. Developed by Aquyre  Biosciences, Inc. after a decade of research, CelTivity™ provides real-time  cancer diagnostics of freshly excised cells and tissue in the operating room  and private practice labs, effectively expanding advanced diagnosis  capabilities.
“Integrating  digital images, data lakes, machine learning, and artificial intelligence,  CelTivity utilizes two proprietary technologies integrated within one exam, producing high-resolution images that delineate tissue microstructures and intracellular  activity up to 1 µm in 3D,” says Bertrand Le Conte de Poly, CEO of Aquyre  Biosciences. “These technologies are full-field optical coherence tomography  (FFOCT), and dynamic cell imaging (DCI). Of significance, is that these  diagnostic results are available within two minutes. The freshly excised sample  can then be sent to pathology, along with the CelTivity data. Moreover, tissue  depth exploration can be achieved at 150 µm below the tissue surface with no  cutting, staining, chemicals, or sectioning required.
Full-Field  Optical Coherence Tomography
  The  CelTivity Full-Field OCT performs noninvasive, high-resolution optical  slicing beneath the tissue surface. The full-field approach offers great potential  in imaging of samples to assist fast diagnostic of cellular and morphological  scale pathologies, such as cancer. It consists of an interference microscope,  or more precisely, a classic Michelson interferometer with a microscope  objective in each arm. The Michelson interferometer produces interference  fringes by splitting a beam of light so that one beam strikes a fixed mirror  and the other a movable mirror. When the reflected beams are brought back  together, an interference pattern results.
  
  An  incoherent light source illuminates the whole field of the microscope  objectives. Due to the low temporal coherence of the source, interference occurs  only when the optical path lengths of the two arms of the interferometer are  identical within 1 µm. When a biological sample is placed under the microscope  objective in the sample arm, the light reflected by the reference mirror interferes with the light reflected or backscattered by the sample structures  contained in a limited volume.
  
  “The  interferometer can be displaced to step the focal plane through different  depths beneath the surface to create high-quality 3D tomographic images,” adds  Le Conte de Poly. “Light-CT captures, en face, images directly using a  megapixel camera and a pair of microscope objectives with lateral resolution  to typically ~1 µm. The FFOCT image displays in gray scale the static optical  contrast of the region of interest. Highly backscattering content like different  fibrous structures (collagen, axons, etc.) appears white, while weakly backscattering  content like cells appears dark, gray, or black.”
  
  
 Dynamic  Cell Imaging
Dynamic  Cell Imaging
  The  CelTivity DCI enhances the cellular contrast by capturing the residual microscopic  intracellular movements in freshly excised tissue. Dynamic cell imaging provides  a dynamic contrast at the intracellular scale which complements the  morphological information provided by FFOCT, thus bringing images up to the  histology level of detail and information richness. 
  
  A  DCI technique consists of recording the time series of each voxel -  a unit of graphic information that defines a  point in three-dimensional space - under examination during a few seconds,  and processes them in order to extract characteristic features of the  subcellular activity to be displayed. From a Fourier analysis of the time  signal, the DCI RGB image is created where the blue channel corresponds to low  frequency moving parts (< 0.5 Hz), the green channel displays medium  frequency moving parts (0.5-5 Hz), and the red channel displays higher  frequency moving parts (5-25 Hz). The signal intensity in each color channel  reflects the dynamics amplitude in each corresponding frequency range.
“DCI images obtained on different breast samples show the potential of the DCI technique to differentiate cancerous from normal tissue and ultimately to discriminate various cell types,” continues Le Conte de Poly.
Vibration  Isolation
  “Because  CelTivity’s technologies function at the micron level, vibration isolation is  critical to maintaining the system’s highest level of operation,” explaiins Le  Conte de Poly. “Footfall from someone walking   by,  the  closing   of doors, HVAC units operating, or elevators in motion create  low-frequency vibrations that can influence FFOCT and DCI imaging.”
“Consequently,  Celtivity is supported by vibration isolation designed to more thoroughly  cancel out low-frequency vibrations,” says Le Conte de Poly. “For this purpose,  negative-stiffness vibration isolation was selected because of its high-performance  capability, and ease of adaptability to hospital and laboratory environments.”
  
  Negative-stiffness vibration isolation was developed by Minus K  Technology, an OEM supplier to manufacturers of scanning probe microscopes,  micro-hardness testers, and other vibration-sensitive instruments and equipment.  These vibration isolators are compact and do not require electricity or  compressed air, which enables sensitive instruments to be located wherever they  are needed. There are no motors, pumps, or chambers, and no maintenance because  there is nothing to wear out. They operate purely in a passive mechanical mode.

What is very advantageous about negative-stiffness isolators is that they achieve a high level of isolation in multiple directions. These isolators have the flexibility of custom tailoring resonant frequencies to 0.5 Hz vertically and horizontally (with some versions at 1.5 Hz horizontally). (Note that for an isolation system with a 0.5 Hz natural frequency, isolation begins at 0.7 Hz and improves with increase in the vibration frequency. The natural frequency is more commonly used to describe the system performance.)
Vertical-motion isolation is provided by a stiff spring that supports a weight load, combined with a negative-stiffness mechanism. The net vertical stiffness is made very low without affecting the static load-supporting capability of the spring. Beam-columns connected in series with the vertical-motion isolator provide horizontal-motion isolation. A beam-column behaves as a spring combined with a negative-stiffness mechanism. The result is a compact passive isolator capable of very low vertical and horizontal natural frequencies and high internal structural frequencies.”
Negative-stiffness isolators deliver very high performance, as measured by a transmissibility curve. Vibration transmissibility is a measure of the vibrations that are transmitted through the isolator relative to the input vibrations. Negative-stiffness isolators, when adjusted to 0.5 Hz, achieve approximately 93 percent isolation efficiency at 2 Hz; 99 percent at 5 Hz; and 99.7 percent at 10 Hz.
Better  Image Quality
  Celtivity’s  technology is the sole technique   providing axial resolution of 1 µm, which gives the highest quality image clarity and precision. It enables image capture on a 1 cm² region of tissue in one  minute, thereby enabling immediate quality control of biopsies.
Full-field optical coherence tomography and dynamic cell imaging produce real-time images showing tissue architecture and intracellular activity data without sample processing or staining, and no need for dyes, contrast agents or tissue freezing.
This  article was written by Jim McMahon, who writes on industrial, manufacturing,  and technology issues. For more information on negative-stiffness isolators,  contact Steve Varma, Minus K Technology, Inc.; Phone 310-348-9656; Fax  310-348-9638; e-mail  request@minusk.com; www.minusk.com. For more information about  Aquyre Biosciences, contact Bertrand Le Conte de Poly, CEO; Phone +33 1 78 96  50 00; e-mail info@ aquyre.com; www.aquyre.com.
| 
 |